What is HC Wainwright’s Forecast for RMTI Q1 Earnings?

Rockwell Medical, Inc. (NASDAQ:RMTI) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Rockwell Medical in a research report issued on Monday, March 24th. HC Wainwright analyst R. Selvaraju forecasts that the company will earn ($0.02) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $3.00 price objective on the stock. The consensus estimate for Rockwell Medical’s current full-year earnings is $0.03 per share. HC Wainwright also issued estimates for Rockwell Medical’s Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at ($0.01) EPS and FY2026 earnings at ($0.06) EPS.

Separately, StockNews.com cut shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th.

Rockwell Medical Stock Performance

RMTI opened at $1.26 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. Rockwell Medical has a 52-week low of $1.26 and a 52-week high of $5.15. The firm has a market cap of $40.72 million, a P/E ratio of -25.20 and a beta of 1.55. The business’s fifty day moving average is $1.83 and its 200-day moving average is $2.59.

Rockwell Medical (NASDAQ:RMTI) last posted its quarterly earnings data on Thursday, March 20th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The company had revenue of $24.67 million for the quarter, compared to the consensus estimate of $23.65 million. Rockwell Medical had a positive return on equity of 8.55% and a negative net margin of 1.25%.

Institutional Investors Weigh In On Rockwell Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in RMTI. Raymond James Financial Inc. bought a new position in shares of Rockwell Medical in the 4th quarter valued at $28,000. Two Sigma Securities LLC acquired a new stake in Rockwell Medical in the fourth quarter valued at about $33,000. Barclays PLC grew its position in Rockwell Medical by 27.5% in the fourth quarter. Barclays PLC now owns 28,854 shares of the company’s stock valued at $59,000 after acquiring an additional 6,229 shares during the last quarter. XTX Topco Ltd raised its stake in Rockwell Medical by 58.0% during the fourth quarter. XTX Topco Ltd now owns 44,962 shares of the company’s stock worth $92,000 after acquiring an additional 16,507 shares in the last quarter. Finally, LPL Financial LLC raised its stake in Rockwell Medical by 91.3% during the fourth quarter. LPL Financial LLC now owns 54,872 shares of the company’s stock worth $112,000 after acquiring an additional 26,191 shares in the last quarter. 23.31% of the stock is currently owned by institutional investors.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.